ROCKET PHARMACEUTICALS, INC. cotiza a 2.30 USD y tiene una capitalización bursátil de $252M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include progra…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.38 | $-0.42 | $-0.38 |
| Estimado | $-0.41 | $0.35 | $-0.45 | $-0.42 |
| Sorpresa | — | -208.6% | +6.7% | +9.5% |
| Métrica | RCKT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -80.5% | -40.4% | -40.1% |
| ROA | -67.5% | -32.0% | -35.5% |
| Current Ratio | 6.38 | 2.84 | +3.54 |
| Debt / Equity | — | 0.28 | — |